MAR 02, 2018 8:00 AM PST

Photoaffinity Probe Developed to Monitor Endogenous Cannabinoid Receptor 2 Expression and Ligand Engagement

WRITTEN BY: Mauri Brueggeman

Researchers in Europe and the United States collaborated to successfully develop a two-step photoaffinity probe to monitor endogenous G-protein coupled receptor (GPCR) cannabinoid receptor 2 (CB2R) expression and ligand engagement.  The group made up of scientists from institutions in The Netherlands, Switzerland, and the US examined the potential for CB2R use in the treatment of tissue injury and inflammatory diseases.  The CBR2 is found in immune system cells and is upregulated as a result of pathophysiological conditions.  They published their results in the Journal of the American Chemical Society in February 2018.

There are hundreds of described G-protein coupled receptors (GPCR) in the literature; GCPRs are a large and diverse family of transmembrane domain receptors that transmit extracellular signals to the cell.  Each contains seven segments that spans the width of the membrane.  GPCRs communicate through G-proteins to activate Ras or other signaling proteins to trigger intracellular signaling pathways. 

The authors write that the CB2R plays a critical role in cell migration and immunosuppression and shares 44% overall homology with the cannabinoid receptor 1 (CB1R) which is found primarily in the central nervous system.  CB2R activation alone may provide therapeutic benefits without side effects of CB1R activation so there has been work done to identify a CB2R agonist.  CB2R agonists like LEI101, HU308, and HU910, as reported by these authors, have demonstrated efficacy for chronic and inflammatory pain, neuro- and nephropathy, and other disorders in animal models.

The researchers faced challenges in determining the type of labeling that would work because of the variable surface expression level of GPCRs.  In addition, normal biochemical methods using antibodies against GPCR cannot be used because CB2R does not currently have specific antibodies against it.  Lastly, because GPCRs change conformation upon the ligand binding, labeling cannot inhibit those changes and signaling cascade process while also needing to avoid degradation.

The result is the development of a two-step photoaffinity-based protein profiling process which utilizes a small ligation handle, a fluorescent tag, and an element to cross-link the product (ligand with receptor) to assess endogenous expression using LEI121.  This is important to help drive research forward through demonstration of CB2R occupancy at the site of inflammation in patients.

Sources: NatureJournal of the American Chemical Society

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
APR 16, 2020
Cannabis Sciences
Nanoemulsion Speeds up THC Absorption in Edibles
APR 16, 2020
Nanoemulsion Speeds up THC Absorption in Edibles
Cannabis products infused with nanoemulsion boast many advantages over more traditionally manufactured edibles, and are ...
APR 15, 2020
Cannabis Sciences
Marijuana May or May Not Actually Help with Pain
APR 15, 2020
Marijuana May or May Not Actually Help with Pain
Cannabis use is often associated with pain relief, but a recent study of medical marijuana use suggests that scientists ...
APR 16, 2020
Cannabis Sciences
Even the Most Experienced Cannabis Users Don't Understand Cannabinoids
APR 16, 2020
Even the Most Experienced Cannabis Users Don't Understand Cannabinoids
Results from a new research study call for better cannabis education programs after a survey of potentially the drug&rsq ...
APR 17, 2020
Cannabis Sciences
Does CBD Really Ease Arthritis Pain?
APR 17, 2020
Does CBD Really Ease Arthritis Pain?
Cannabis products are increasingly used to treat chronic pain from arthritis. As its non psychoactive ingredient, cannab ...
JUN 18, 2020
Health & Medicine
People Taking Medicinal Cannabis Report Greater Well-Being
JUN 18, 2020
People Taking Medicinal Cannabis Report Greater Well-Being
Legalization of medicinal cannabis is now fairly widespread, yet there's been a paucity of data collected on patient exp ...
JUN 20, 2020
Cannabis Sciences
Prolonged Cannabis Use May Prevent Migraines
JUN 20, 2020
Prolonged Cannabis Use May Prevent Migraines
Between 1% and 2% of the world's population suffers from chronic migraines. Researchers from Israel have now found t ...
Loading Comments...